- Home
- SVCO vs FBRX Comparison
SVCO vs FBRX Comparison
Compare SVCO & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVCO
- FBRX
- Stock Information
- Founded
- SVCO 1984
- FBRX N/A
- Country
- SVCO United States
- FBRX United States
- Employees
- SVCO N/A
- FBRX N/A
- Industry
- SVCO
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- SVCO
- FBRX Health Care
- Exchange
- SVCO NYSE
- FBRX Nasdaq
- Market Cap
- SVCO 140.5M
- FBRX 154.5M
- IPO Year
- SVCO 2024
- FBRX N/A
- Fundamental
- Price
- SVCO $4.56
- FBRX $11.60
- Analyst Decision
- SVCO Strong Buy
- FBRX Strong Buy
- Analyst Count
- SVCO 5
- FBRX 2
- Target Price
- SVCO $17.00
- FBRX $61.00
- AVG Volume (30 Days)
- SVCO 135.6K
- FBRX 73.6K
- Earning Date
- SVCO 08-06-2025
- FBRX 08-13-2025
- Dividend Yield
- SVCO N/A
- FBRX N/A
- EPS Growth
- SVCO N/A
- FBRX N/A
- EPS
- SVCO N/A
- FBRX N/A
- Revenue
- SVCO $57,883,000.00
- FBRX N/A
- Revenue This Year
- SVCO $14.25
- FBRX N/A
- Revenue Next Year
- SVCO $15.85
- FBRX N/A
- P/E Ratio
- SVCO N/A
- FBRX N/A
- Revenue Growth
- SVCO 3.65
- FBRX N/A
- 52 Week Low
- SVCO $3.55
- FBRX $4.11
- 52 Week High
- SVCO $19.07
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- SVCO N/A
- FBRX 53.91
- Support Level
- SVCO N/A
- FBRX $10.02
- Resistance Level
- SVCO N/A
- FBRX $10.99
- Average True Range (ATR)
- SVCO 0.00
- FBRX 0.86
- MACD
- SVCO 0.00
- FBRX -0.06
- Stochastic Oscillator
- SVCO 0.00
- FBRX 60.78
About SVCO SILVACO GROUP INC
Silvaco Group Inc is a provider of technology computer aided design (TCAD) software, electronic data automation (EDA) software and semiconductor intellectual property (SIP). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the technology behind the chip and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).